(01)Overview
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, a chain of 15 amino acids, derived from a sequence found in a protective protein in human gastric juice. It's stable in gastric conditions, which is part of why it has drawn so much research interest.
Most published BPC-157 research is preclinical. It has looked at the peptide's effects on tendon, ligament and muscle repair, gastrointestinal lining integrity, angiogenesis (new blood vessel formation) and nitric oxide signaling.
Research areas: tissue repair, tendon and ligament healing, gastrointestinal integrity, angiogenesis.
Each vial contains 10 mg of lyophilized BPC-157. Every batch is third-party tested, and a COA is available for each lot.
For research use only. Not for human or veterinary use.
Research areas
- Tissue repair & recovery research
What BPC-157 is
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, GEPPPGKPADDAGLV, derived from a partial sequence of a protein isolated from human gastric juice. Unlike most short peptides, it is reported to stay stable in gastric conditions, which is part of why it has attracted research interest.
Why researchers study it
Most BPC-157 literature is preclinical, in cell culture and animal models. It covers tendon, ligament and muscle repair, gastrointestinal mucosal integrity, angiogenesis and VEGFR2 signalling, and interactions with the nitric-oxide system. Common in-vitro work includes fibroblast migration and endothelial tube-formation assays.
Regulatory status
BPC-157 is not an approved drug. Published human data are very limited, and it is supplied by Darkside Labs strictly as a research material for laboratory work.





